Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,024 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.
Schiller JH, Adak S, Feins RH, Keller SM, Fry WA, Livingston RB, Hammond ME, Wolf B, Sabatini L, Jett J, Kohman L, Johnson DH. Schiller JH, et al. Among authors: wolf b. J Clin Oncol. 2001 Jan 15;19(2):448-57. doi: 10.1200/JCO.2001.19.2.448. J Clin Oncol. 2001. PMID: 11208838 Clinical Trial.
Paclitaxel and concurrent radiation for gastric cancer.
Safran H, Wanebo HJ, Hesketh PJ, Akerman P, Ianitti D, Cioffi W, DiPetrillo T, Wolf B, Koness J, McAnaw R, Moore T, Chen MH, Radie-Keane K. Safran H, et al. Among authors: wolf b. Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):889-94. doi: 10.1016/s0360-3016(99)00436-8. Int J Radiat Oncol Biol Phys. 2000. PMID: 10705010 Clinical Trial.
Lower extremity lymphedema in patients with gynecologic cancer: Validation of the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) in German language and investigation of lymphedema real-world treatment.
Meyer H, Hinz A, Weisgerber C, Pilny A, Dornhöfer N, Mehnert-Theuerkauf A, Aktas B, Wolf B. Meyer H, et al. Among authors: wolf b. Arch Gynecol Obstet. 2024 Dec 23. doi: 10.1007/s00404-024-07886-4. Online ahead of print. Arch Gynecol Obstet. 2024. PMID: 39715839
First results of migoprotafib, a potent and highly selective Src homology-2 domain-containing phosphatase 2 (SHP2) inhibitor in patients with advanced solid tumors.
Johnson ML, Wolf BB, Wang JS, Philipovskiy A, Shapiro GI, Bockorny B, Guo W, Shen J, Jen KY, LeRose M, Hunter TL, Padval M, Schmidt-Kittler O, Bhatia N, Dubey S, Suchomel J, Bendell JC, Jauhari S, Eng-Wong J, Lin JJ. Johnson ML, et al. Among authors: wolf bb. Mol Cancer Ther. 2024 Dec 5. doi: 10.1158/1535-7163.MCT-24-0466. Online ahead of print. Mol Cancer Ther. 2024. PMID: 39632729
2,024 results